MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$20,000K
Net Income
-$20,908K
Net Profit Margin
-104.54%
EPS
-$0.42
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-03-31
2025-09-30
2025-06-30
Collaboration revenue
20,000
-
-
Research and development
32,716
22,279
22,680
General and administrative
-
7,707
6,816
Selling, general and administrative
11,499
-
-
Total operating expenses
44,215
29,986
29,496
Loss from operations
-24,215
-29,986
-29,496
Interest income
4,358
3,061
2,764
Total other income, net
4,358
3,061
2,764
Net loss
-19,857
-26,925
-26,732
Change in unrealized gains (losses) on investments, net of tax
-1,051
221
19
Total other comprehensive income (loss)
-1,051
221
19
Comprehensive loss
-20,908
-26,704
-26,713
Basic EPS
-0.42
-0.71
-0.75
Diluted EPS
-0.42
-0.71
-0.75
Basic Average Shares
47,236,618
37,931,170
35,444,635
Diluted Average Shares
47,236,618
37,931,170
35,444,635
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$20,908K
Interest income
$4,358K
Net loss
-$19,857K
Total other
comprehensive income (loss)
-$1,051K
Total other income,
net
$4,358K
Loss from operations
-$24,215K
Change in unrealized
gains (losses) on...
-$1,051K
Collaboration revenue
$20,000K
Total operating
expenses
$44,215K
Research and development
$32,716K
Selling, general and
administrative
$11,499K
Buy us a coffee
Rapport Therapeutics, Inc. (RAPP)
Rapport Therapeutics, Inc. (RAPP)